Search
Skip to Search Results- 1Betageri, Gurupadappa.
- 1Da Silveira Cavalcante, Luciana
- 1Dong, Cunji.
- 1Fan, Chris Zhiming.
- 1Fitzsimmons, Ross
- 1Gupta, Nancy
-
Novel Agents Inhibiting Hepatitis C Virus; Application to Prevention of Re-infection after Liver Transplantation
DownloadFall 2013
Recurrent Hepatitis C virus infection drives inferior outcomes experienced by patients undergoing liver transplantation due to HCV-associated liver disease. Existing therapies exhibit increased toxicity, poor efficacy, and profound patient intolerability in the immediate transplantation period....
-
Spring 2012
The following thesis describes original studies assessing the gene delivery efficacy of novel non-viral carrier combinations. The first panel of non-viral carriers tested are termed AVPs (artificial viral particles), in reference to their structural similarity to enveloped viruses, and were...
-
Spring 2017
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), continues to be a leading infectious cause of death worldwide with approximately 10 million new cases and 2 million deaths attributed annually. There has been resurgence in active TB infections since 1980s and the World Health...
-
Preparation of liposomes and Encapsulation of Bioactives Using Supercritical Carbon Dioxide
DownloadSpring 2017
Liposomes are versatile vesicles of a phospholipid bilayer, which offer great protection for active compounds. Encapsulated compounds can be protected from the unfavorable external conditions so that their chemical stability and bioavailability can be greatly enhanced. The supercritical carbon...
-
Fall 2017
Da Silveira Cavalcante, Luciana
Red blood cells (RBCs) are the most commonly used components in cell therapy and their transfusion save millions of lives every year. These benefits were only achieved through advances in blood banking storage techniques that guarantee an available supply of blood to support medical emergencies...